|
gptkbp:instanceOf
|
gptkb:cancer
gptkb:disease
|
|
gptkbp:accountsFor
|
about 85% of lung cancers
|
|
gptkbp:affectsOrgan
|
gptkb:cancer
|
|
gptkbp:canMetastasizeTo
|
gptkb:bone
brain
liver
adrenal glands
|
|
gptkbp:diagnosedBy
|
gptkb:CT_scan
imaging
PET scan
biopsy
|
|
gptkbp:hasBiomarker
|
gptkb:ALK_rearrangement
gptkb:EGFR_mutation
gptkb:KRAS_mutation
gptkb:PD-L1_expression
|
|
gptkbp:hasFiveYearSurvivalRate
|
about 25% (varies by stage)
|
|
gptkbp:ICD-10_code
|
C34
|
|
gptkbp:isMoreCommonIn
|
men
older adults
|
|
gptkbp:medianAge
|
about 70 years
|
|
gptkbp:prognosis
|
varies by stage
|
|
gptkbp:riskFactor
|
smoking
exposure to asbestos
exposure to radon
|
|
gptkbp:stageName
|
gptkb:TNM
|
|
gptkbp:standsFor
|
gptkb:Non-Small_Cell_Lung_Cancer
|
|
gptkbp:subspecies
|
gptkb:cancer
gptkb:large_cell_carcinoma
|
|
gptkbp:symptom
|
cough
shortness of breath
chest pain
|
|
gptkbp:treatment
|
gptkb:crizotinib
gptkb:bevacizumab
gptkb:osimertinib
gptkb:radiation_therapy
gptkb:immunotherapy
gptkb:atezolizumab
gptkb:carboplatin
gptkb:cisplatin
gptkb:pembrolizumab
gptkb:targeted_therapy
gptkb:nivolumab
surgery
chemotherapy
docetaxel
paclitaxel
|
|
gptkbp:type
|
gptkb:cancer
|
|
gptkbp:bfsParent
|
gptkb:Non-Small_Cell_Lung_Cancer
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NSCLC
|